{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:13:33Z","timestamp":1793146413074,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Huai\u2019an City Science and Technology Project under Grant","award":["HABL202261"],"award-info":[{"award-number":["HABL202261"]}]},{"name":"the Fundamental Research Funds for the Central Universities under Grant","award":["JUSRP123080"],"award-info":[{"award-number":["JUSRP123080"]}]},{"name":"Jiangsu Maternal and Child Health Research Project","award":["F202212"],"award-info":[{"award-number":["F202212"]}]},{"name":"National Natural Science Foundation of China under Grant","award":["82073551"],"award-info":[{"award-number":["82073551"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72909-8","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:25:00Z","timestamp":1727454300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression"],"prefix":"10.1038","volume":"14","author":[{"given":"Chao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaosheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"6","key":"72909_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med.390(6), 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"72909_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","volume":"30","author":"NP Chalasani","year":"2009","unstructured":"Chalasani, N. P. et al. Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemp. Clin. Trials. 30(1), 88\u201396 (2009).","journal-title":"Contemp. Clin. Trials"},{"key":"72909_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2022.12.087","volume":"195","author":"DF Lin","year":"2023","unstructured":"Lin, D. F. et al. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice. Free Radic. Biol. Med.195, 199\u2013218 (2023).","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"72909_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","volume":"24","author":"L Hoyles","year":"2018","unstructured":"Hoyles, L. et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat. Med.24(7), 1070 (2018).","journal-title":"Nat. Med."},{"issue":"5","key":"72909_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J. et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat. Rev. Gastroenterol. Hepatol.17(5), 279\u2013297 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"72909_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3350\/cmh.2020.0129","volume":"27","author":"ECD Jennison","year":"2021","unstructured":"Jennison, E. C. D. & Byrne. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clin. Mol. Hepatol.27(1), 22\u201343 (2021).","journal-title":"Clin. Mol. Hepatol."},{"key":"72909_CR7","doi-asserted-by":"crossref","unstructured":"Koning, M. et al. Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies. Gut Microbes, 15(1). (2023).","DOI":"10.1080\/19490976.2023.2226922"},{"issue":"8","key":"72909_CR8","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/jgh.15487","volume":"36","author":"M Iwaki","year":"2021","unstructured":"Iwaki, M. et al. Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol.36(8), 2275\u20132284 (2021).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"648","key":"72909_CR9","doi-asserted-by":"publisher","first-page":"eabk0855","DOI":"10.1126\/scitranslmed.abk0855","volume":"14","author":"H Leung","year":"2022","unstructured":"Leung, H. et al. Risk assessment with gut microbiome and metabolite markers in NAFLD development. Sci. Transl. Med.14(648), eabk0855 (2022).","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"72909_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","volume":"20","author":"F Li","year":"2021","unstructured":"Li, F. et al. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and meta-analysis. Lipids Health Dis.20(1), 22 (2021).","journal-title":"Lipids Health Dis."},{"issue":"3","key":"72909_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo, K. et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 150(3), 626\u2013637.e7 (2016).","journal-title":"Gastroenterology"},{"key":"72909_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/liv.13653","volume":"38","author":"P Bedossa","year":"2018","unstructured":"Bedossa, P. Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: why liver biopsy is essential. Liver Int.38, 64\u201366 (2018).","journal-title":"Liver Int."},{"issue":"1","key":"72909_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2020.11.010","volume":"33","author":"SR Sharpton","year":"2021","unstructured":"Sharpton, S. R. et al. Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease. Cell. Metab.33(1), 21\u201332 (2021).","journal-title":"Cell. Metab."},{"key":"72909_CR14","doi-asserted-by":"crossref","unstructured":"Vallianou, N. et al. Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives. Biomolecules, 12(1). (2021).","DOI":"10.3390\/biom12010056"},{"issue":"3","key":"72909_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.aohep.2019.04.006","volume":"18","author":"SMB Duarte","year":"2019","unstructured":"Duarte, S. M. B. et al. Microbiota and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis (NAFLD\/NASH). Ann. Hepatol.18(3), 416\u2013421 (2019).","journal-title":"Ann. Hepatol."},{"key":"72909_CR16","unstructured":"Ren, S. M. et al. Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi\u2009=\u2009Zhonghua ganzangbing zazhi\u2009=\u2009Chinese journal of hepatology,27(5), 369\u2013375. (2019)."},{"issue":"37","key":"72909_CR17","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.3748\/wjg.v27.i37.6161","volume":"27","author":"SP Sharma","year":"2021","unstructured":"Sharma, S. P. et al. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J. Gastroenterol.27(37), 6161\u20136179 (2021).","journal-title":"World J. Gastroenterol."},{"key":"72909_CR18","doi-asserted-by":"crossref","unstructured":"Del Barrio, M. et al. Faecal microbiota transplantation, paving the way to treat non-alcoholic fatty liver disease. Int. J. Mol. Sci., 24(7). (2023).","DOI":"10.3390\/ijms24076123"},{"issue":"2","key":"72909_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4161\/gmic.27651","volume":"5","author":"S Miquel","year":"2014","unstructured":"Miquel, S. et al. Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Gut Microbes. 5(2), 146\u2013151 (2014).","journal-title":"Gut Microbes"},{"issue":"7","key":"72909_CR20","doi-asserted-by":"publisher","first-page":"e2118811","DOI":"10.1001\/jamanetworkopen.2021.18811","volume":"4","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Association of insulin resistance and type 2 diabetes with gut microbial diversity: a microbiome-wide analysis from population studies. JAMA Netw. Open.4(7), e2118811 (2021).","journal-title":"JAMA Netw. Open."},{"key":"72909_CR21","doi-asserted-by":"publisher","first-page":"108246","DOI":"10.1016\/j.jnutbio.2019.108246","volume":"74","author":"L Che","year":"2019","unstructured":"Che, L. et al. Inter-correlated gut microbiota and SCFAs changes upon antibiotics exposure links with rapid body-mass gain in weaned piglet model. J. Nutr. Biochem.74, 108246 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"72909_CR22","doi-asserted-by":"crossref","unstructured":"Hu, Y. H. et al. Gut microbiome and stages of diabetes in middle-aged adults: CARDIA microbiome study. Nutr. Metab. 20(1) (2023).","DOI":"10.1186\/s12986-022-00721-0"},{"issue":"12","key":"72909_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0181-3","volume":"50","author":"Y Xiao","year":"2018","unstructured":"Xiao, Y. et al. Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling. Exp. Mol. Med.50(12), 1\u201314 (2018).","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"72909_CR24","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A. et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 165(6), 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"72909_CR25","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1017\/gheg.2020.2","volume":"5","author":"C Torp Austvoll","year":"2020","unstructured":"Torp Austvoll, C. et al. Health impact of the Anthropocene: the complex relationship between gut microbiota, epigenetics, and human health, using obesity as an example. Glob Health Epidemiol. Genom. 5, e2 (2020).","journal-title":"Glob Health Epidemiol. Genom"},{"issue":"1","key":"72909_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4196\/kjpp.2018.22.1.23","volume":"22","author":"M Kim","year":"2018","unstructured":"Kim, M. et al. Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing\u2019s syndrome. Korean J. Physiol. Pharmacol.22(1), 23\u201333 (2018).","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"7285","key":"72909_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464(7285), 59\u201365 (2010).","journal-title":"Nature"},{"key":"72909_CR28","doi-asserted-by":"crossref","unstructured":"Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 352(6285), 565\u2013569 (2016).","DOI":"10.1126\/science.aad3369"},{"key":"72909_CR29","doi-asserted-by":"crossref","unstructured":"Song, H. et al. Evaluation of prebiotics through an in vitro gastrointestinal digestion and fecal fermentation experiment: further idea on the implementation of machine learning technique. Foods, 11(16). (2022).","DOI":"10.3390\/foods11162490"},{"key":"72909_CR30","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Imbalance of microbacterial diversity is associated with functional prognosis of stroke. Neural Plasticity, 2023. (2023).","DOI":"10.1155\/2023\/6297653"},{"key":"72909_CR31","doi-asserted-by":"crossref","unstructured":"Effenberger, M. et al. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma. Hepatol. Commun.7(7), (2023).","DOI":"10.1097\/HC9.0000000000000182"},{"key":"72909_CR32","doi-asserted-by":"crossref","unstructured":"Ikeda, T. A. et al. Short-chain Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases. Pharmacol. Ther.. 239 (2022).","DOI":"10.1016\/j.pharmthera.2022.108273"},{"issue":"5","key":"72909_CR33","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.fshw.2022.04.023","volume":"11","author":"DZ Hou","year":"2022","unstructured":"Hou, D. Z. et al. Alteration of fecal microbiome and metabolome by mung bean coat improves diet-induced non-alcoholic fatty liver disease in mice. Food Sci. Hum. Wellness. 11(5), 1259\u20131272 (2022).","journal-title":"Food Sci. Hum. Wellness"},{"issue":"13","key":"72909_CR34","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1021\/jf900470c","volume":"57","author":"T Kondo","year":"2009","unstructured":"Kondo, T. et al. Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. J. Agric. Food Chem.57(13), 5982\u20135986 (2009).","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"72909_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJT Morrison","year":"2016","unstructured":"Morrison, D. J. T. & Preston formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 7(3), 189\u2013200 (2016).","journal-title":"Gut Microbes"},{"key":"72909_CR36","doi-asserted-by":"crossref","unstructured":"Sarkar, A. et al., Butyrate limits inflammatory macrophage niche in NASH. Cell Death Dis.14(5) (2023).","DOI":"10.1038\/s41419-023-05853-6"},{"issue":"5","key":"72909_CR37","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00394-020-02431-w","volume":"60","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. Eur. J. Nutr.60(5), 2317\u20132330 (2021).","journal-title":"Eur. J. Nutr."},{"key":"72909_CR38","doi-asserted-by":"crossref","unstructured":"Roychowdhury, S. et al. A designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice. Nutrients, 11(1). (2019).","DOI":"10.3390\/nu11010097"},{"key":"72909_CR39","doi-asserted-by":"crossref","unstructured":"Ye, J. et al. Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front. Microbiol.9, 1967 (2018).","DOI":"10.3389\/fmicb.2018.01967"},{"issue":"7","key":"72909_CR40","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41591-019-0485-4","volume":"25","author":"J Scheiman","year":"2019","unstructured":"Scheiman, J. et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med.25(7), 1104\u20131109 (2019).","journal-title":"Nat. Med."},{"key":"72909_CR41","doi-asserted-by":"publisher","first-page":"108929","DOI":"10.1016\/j.foodres.2019.108929","volume":"130","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice. Food Res. Int.130, 108929 (2020).","journal-title":"Food Res. Int."},{"issue":"7","key":"72909_CR42","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1096\/fj.202000455R","volume":"34","author":"AC Tengeler","year":"2020","unstructured":"Tengeler, A. C. et al. Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr-\/-.Leiden mice. FASEB J.34(7), 9575\u20139593 (2020).","journal-title":"FASEB J."},{"issue":"1","key":"72909_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"PHJ Louis","year":"2017","unstructured":"Louis, P. H. J. & Flint. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol.19(1), 29\u201341 (2017).","journal-title":"Environ. Microbiol."},{"issue":"1","key":"72909_CR44","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","volume":"8","author":"HE Da Silva","year":"2018","unstructured":"Da Silva, H. E. et al. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Sci. Rep.8(1), 1466 (2018).","journal-title":"Sci. Rep."},{"issue":"33","key":"72909_CR45","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C De Filippo","year":"2010","unstructured":"De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA107(33), 14691\u201314696 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"72909_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2000","unstructured":"Bellentani, S. et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med.132(2), 112\u2013117 (2000).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"72909_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams, C. D. et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 140(1), 124\u2013131 (2011).","journal-title":"Gastroenterology"},{"issue":"1","key":"72909_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jgh.12428","volume":"29","author":"Z Li","year":"2014","unstructured":"Li, Z. et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J. Gastroenterol. Hepatol.29(1), 42\u201351 (2014).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"72909_CR49","doi-asserted-by":"crossref","unstructured":"Castera, L. et al. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology156(5) (2019).","DOI":"10.1053\/j.gastro.2018.12.036"},{"issue":"1","key":"72909_CR50","doi-asserted-by":"publisher","first-page":"21925","DOI":"10.1038\/s41598-022-25843-6","volume":"12","author":"A Nogami","year":"2022","unstructured":"Nogami, A. et al. Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD. Sci. Rep.12(1), 21925 (2022).","journal-title":"Sci. Rep."},{"key":"72909_CR51","doi-asserted-by":"crossref","unstructured":"Garteiser, P., Castera L., et al. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates. JHEP Rep. Innov. Hepatol.3(6), 100381 (2021).","DOI":"10.1016\/j.jhepr.2021.100381"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72909-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:26:10Z","timestamp":1727454370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72909-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72909"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72909-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"24 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22385"}}